2025 CGA-IGC Annual Meeting
Legend Scientific Sessions
Committee Meetings & Social Events
Abstract
Sponsored Symposium
*All Industry Symposia will be held in a separate hall from the plenary hall.
THURSDAY, OCTOBER 9
Time Slot Meeting Hall
07:00 - 07:45 Slot for Tier 2 Sponsored Breakfast Symposium
08:00 - 08:15 Welcome & Housekeeping
Beth Dudley Yurkovich, CGA-IGC President
08:15 - 09:00 Session I: James Church Lecture
Moderator: Matthew Kalady
Introduction, Matthew Kalady
James Church Lecture: A Short History of CGA-IGC, James Church
Q&A
09:00 - 09:55 Session II: Debate
Moderator: Marianne Dubard-Gault
Is Bigger Really Better? Debating Genetic Test Panel Size, Maegan Roberts & Dana Farengo-Clark
09:55 - 10:15 AM BREAK
10:15 - 12:15 Session III: Advocacy
Moderators: Emma Keel & Gautam Mankaney
Addressing Financial Toxicity For Patients With Hereditary GI Syndromes, Yvonne Bombard
Q&A
Healthcare Policy Advocacy For Hereditary GI Syndromes, Swati Patel
Q&A
Genetic Counselor Advocacy: Creating A Seat At The Table, Sara Pirzadeh-Miller
Q&A,
Using Patient Advocacy To Fight For Change, Ben White
Q&A
12:15 - 13:30 LUNCH BREAK
12:20 - 13:20 Slot for Tier 1 Sponsored Lunch Symposium
13:30 - 15:00 Presidential Plenary I
Moderators: Bryson Katona & Beth Dudley Yurkovich
Financial Distress Among Young Adults With Early-Onset Gastrointestinal Cancers: A Call To Action, Marta Puzzono
Genetic Cancer Prevention Clinic: Clinical Outcomes Review, Jacqueline Mersch
Mutyh-Associated Polyposis In Adolescents: A Case Series, Kristin Zelley
Cigarette Smoking And Age Of Pancreatic Adenocarcinoma Diagnosis For Hereditary Pancreatic Cancer Patients, Timothy Shu
Repeat Gastric Body And Antrum Biopsies In Lynch Syndrome Yield Newly Identified Gastric Intestinal Metaplasia, Jessica Vadaketh
Cancer Penetrance Among CTNNA1 Loss-Of-Function Carriers: Initial Cancer Risk Estimates From The CTNNA1 Familial Expansion (CAFÉ) Study, Dana Farengo-Clark
DNA Mismatch Repair Deficiency And Clinical Features Of Prostate Cancer Among Lynch Syndrome Patients, Linda Rodgers-Fouche
Spatially Resolved Transcriptomic Analysis Of Gastric Precancers Arising In Germline CDH1 Variant Carriers, Jeremy Davis
Analysis Of Missense Variants In RPS20 And An Association With Colorectal Cancer Predisposition, Jennifer Herrera-Mullar
Evaluating The Diagnostic Yield Of Updated Genetic Testing In Individuals With Idiopathic Adenomatous Polyposis, Blake Rowell
15:00 - 15:40 PM BREAK
15:05 - 15:35 CCARE Lynch Poster Walk
15:40 - 17:00 Session IV: Oncology
Moderators: Mo Abbas & Darryl Outlaw
Watch And Wait: Management Of Mismatch Repair Proficient Rectal Cancer, Rodrigo Oliva Perez
Q&A
Non-Operative Management Of Mismatch Repair Deficient Cancers, Zsofia Stadler
Q&A
How We Do It: DPYD variant testing prior to the use of fluoropyrimidine-based chemotherapy among GI cancer patients: An exploration of current approaches and opportunities for increased Genetic Counselor involvement, Madeline Smith & Daniel Hertz & Arravinth Anantharajah & Heather Glessner
Q&A
17:00 - 18:00 Session V: Hereditary Live
Moderator: Joshua Sommovilla & David Liska
Panelists: Lisen Axell & Brian Sullivan & Maria McGreevy
18:00 - 19:00 Poster Session I
FRIDAY, OCTOBER 10
Time Slot Meeting Hall
07:00 - 07:45 Slot for Tier 2 Sponsored Breakfast Symposium
08:00 - 08:15 Welcome & Housekeeping
Beth Dudley Yurkovich, CGA-IGC President
08:15 - 10:00 Session VI: Lynch Syndrome
Moderators: Chinedu Ukaegbu & Sheila Rustgi
What's Different About Lynch-Associated Gynecologic Cancers?, Ying Liu
Q&A
Lynch Syndrome Network Consensus (Lynsync) International Guidelines, Giulia Martina Cavestro
Q&A
Capp3: An Update On Aspirin Chemoprevention In Lynch Sydnrome, John Burn
Q&A
Emerging Treatments For Lynch-Related Cancers, Asaf Maoz
Q&A
10:00 - 10:20 AM BREAK
10:20 - 11:05 Session VII: Anne Krush Lecture
Moderator: Cathryn Koptiuch
Introduction, Cathryn Koptiuch
Anne Krush Lecture: Clinical Management For Variants With Discrepant Classifications, Wendy Kohlmann
Q&A
11:05 - 12:15 Session VIII: Delivery of Care
Moderators: Lauren Gima & Jennifer Fijor
Reducing Diparities In Cancer Outcomes For Local Communities: The Cancer Care Equity Program, Ludmila Svoboda
Q&A
How We Do It: Leveraging Innovation to Improve Access to Hereditary Cancer Genetic Testing in an NP Led Clinic, Ashley Hendershot & Carol Shaw & Patricia Mallaber
Q&A
Integrating Genetic Social Work to Address Psychosocial Challenges in Hereditary Cancer Care, Emily Epstein
12:15 - 13:30 LUNCH BREAK
12:20 - 13:20 Slot for Tier 1 Sponsored Lunch Symposium
13:30 - 15:00 Presidential Plenary II
Moderators:Beth Dudley Yurkovich & Elana Levinson
Evaluation Of An Employer-Based Cancer Benefit Program Facilitated By Genetic Counselors, Kelly Knickelbein
Assessment Of Reasons For Pancreatic Cancer Surveillance Cessation Or Deferral Amongst High-Risk Individuals, Grace Snyder
Expanding The Spectrum: Extra-Colonic Malignancies In MUTYH-Associated Polyposis, Lisa A Laguardia
Comparing And Contrasting Lived Experiences Of Patients With Lynch Syndrome And Polyposis Syndromes, John Krebsbach
The Longest Documented Follow-Up Of A Large Ampullary Adenoma In FAP: A 30-Year Cancer-Free Case, Youssef Soliman
Post Operative Outcomes Of CDH1 Carriers Undergoing Gastrectomy– Results Form The GASTRIC Consortium, Ajay Bansal
Real World Adherence To Colorectal Cancer Screening In Patients With MLH1 And MSH2 Lynch Syndrome At A Tertiary Community Cancer Center, Marianne Dubard-Gault
Identifying Barriers To Hispanic/Latino Participation In Cancer Clinical Trials: A Pilot Study, José G. Guillem
Who’s In The Driver’s Seat? Assessment Of Germline Drivers Of Early-Onset Endometrial Cancer, Juliet Milani
Rate And Root Cause Analysis Of Post-Colonoscopy Colorectal Cancer In Lynch Syndrome: The Potential Of The LINEAGE Consortium, Minh Do
Cancer Risk In Individuals With Hamartomatous Polyposis Syndromes: A Call For Collaboration, Bryson Katona
Perceptions Of Gastric Cancer Risk And Attitudes Towards Endoscopic Surveillance In Patients With CDH1 Pathogenic Variants, Conner Lombardi
15:00 - 15:20 PM BREAK
15:20 - 16:50 Session VIII: Surveillance and Prevention
Moderators: Rachel Hodan & Dan Chung
Dermatologic Findings In Hereditary Gi Syndromes: Diagnosis And Surveillance, Ata Moshiri
Q&A
Using Molecular Cyst Fluid Analysis For Risk Stratification In Hereditary Pancreatic Cancer Surveillance, Aatur Singhi
Q&A
How Do Different Endoscopic Techniques Affect Colonoscopy Outcomes?, Pooja Dharwadker
Q&A
17:00 - 18:00 Session IX: Jeopardy
Moderators: Mike Hall & Kim Hilfrank
18:00 - 19:00 Poster Session II
SATURDAY, OCTOBER 11
Time Slot Meeting Hall
07:00 - 07:45 Slot for Tier 2 Sponsored Breakfast Symposium
08:00 - 08:15 Welcome & Housekeeping
Beth Dudley Yurkovich, CGA-IGC President
08:15 - 09:00 Session X: Charis Eng Lecture
Moderator: Brandie Leach
Introduction, Brandie Leach
Charis Eng Lecture: What You Should Know About PTEN, Joanne Ngeow
Q&A
09:00 - 10:30 Session XI: Upper GI Management
Moderators: Jennifer Weiss & Joshua Melson
Spigelman Classification: Is It Time For A Change?, Alessandro Mannucci
Q&A
Implications Of Metabolic Surgery And Medication In Patients With Hereditary GI Syndromes, Rickesha Wilson
Q&A
Surgical Management Of Duodenal And Ampullary Lesions, Dominic Sanford
Q&A
10:30 - 10:50 AM BREAK
10:50 - 12:15 Session XII: Population Based Testing
Moderators: Julie Moskowitz & Heather Hampel
The Current State Of Population Based Genetic Testing, Stephanie Cohen
Q&A
How We Do It: From Awareness to Action: Improving Access to Hereditary Cancer Genetic Testing through Population Screening in a Community Health System, Allison DePersia & Breanne Prindeville & Yvette Shannon & Sarah Choi
Q&A
Ethical Considerations For The Future Of Population Based Genetic Testing, Julie Harris-Wai
Q&A
12:15 - 13:30 LUNCH BREAK
12:20 - 13:20 Slot for Tier 1 Sponsored Lunch Symposium
13:30 - 15:00 Presidential Plenary III
Moderators: Elana Levinson & TBA
Systematic Functional Characterisation Of CDH1 Variants, Joseph (Sefi) Rosenbluh
Somatic And Molecular Alterations In Colorectal Cancer By Birth Cohort, Ophir Gilad
Causes Of Death Among Individuals With Lynch Syndrome (LS) In The Immunotherapy Era, Asaf Maoz
Controversial Areas In Pancreatic Cancer Surveillance: A Survey Across The International Pancreatic Cancer Early Detection (PRECEDE) Consortium, Anjeli Manam
Effect Of GLP-1 Receptor Agonist Use On Polyp Burden In Familial Adenomatous Polyposis: A Case Series, Diana Jomaa
Beyond Familial Adenomatous Polyposis: Genotype-Phenotype Correlations Discern Germline Versus Somatic APC Whole-Gene Deletions Among 860,000 Tests, Katherine Belshe
15:00 - 16:00 CGA-IGC Business Meeting &
Presidential Transition
Beth Dudley Yurkovich & Mike Hall & Bryson Katona
Post Meeting Wrap Up
Elana Levinson